CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | BEHRENS M KATHLEEN Director | Grant or award | +1,846 | 176,839 | ||
| 2024-03-01 | BEHRENS M KATHLEEN Director | Grant or award · Stock Option (right to buy) | +3,679 | 3,679 | ||
| 2024-03-01 | Nicaise Claude Director | Grant or award | +1,846 | 18,174 | ||
| 2024-03-01 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +3,679 | 3,679 | ||
| 2024-03-01 | Boor Kathryn Jean Director | Grant or award | +1,846 | 8,277 | ||
| 2024-03-01 | Boor Kathryn Jean Director | Grant or award · Stock Option (right to buy) | +3,679 | 3,679 | ||
| 2024-03-01 | Barry Richard Director | Grant or award | +1,846 | 2,931,688 | ||
| 2024-03-01 | Barry Richard Director | Grant or award · Stock Option (right to buy) | +3,679 | 3,679 | ||
| 2024-03-01 | Mayo Stephen Director | Grant or award | +1,846 | 9,756 | ||
| 2024-03-01 | Mayo Stephen Director | Grant or award · Stock Option (right to buy) | +3,679 | 3,679 | ||
| 2024-03-01 | Chambers Michael Andrew Director | Grant or award | +1,846 | 8,277 | ||
| 2024-03-01 | Chambers Michael Andrew Director | Grant or award · Stock Option (right to buy) | +3,679 | 3,679 | ||
| 2024-03-01 | Brown Ryan Edward EVP, General Counsel | Shares withheld for taxes | −269 | $126.19 | $34K | 27,827 |
| 2024-03-01 | Brown Ryan Edward EVP, General Counsel | Grant or award | +6,000 | 33,827 | ||
| 2024-03-01 | Brown Ryan Edward EVP, General Counsel | Sale | −2,000 | $125.34 | $251K | 31,827 |
| 2024-03-01 | Brown Ryan Edward EVP, General Counsel | Grant or award · Stock Option (right to buy) | −12,500 | 12,500 | ||
| 2024-03-01 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −778 | $126.19 | $98K | 65,222 |
| 2024-03-01 | Rodino-Klapac Louise Head of R&D, CSO | Grant or award | +6,000 | 71,222 | ||
| 2024-03-01 | Rodino-Klapac Louise Head of R&D, CSO | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-03-01 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −251 | $126.19 | $32K | 22,836 |
Page 13 of 22 · 424 trades